- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Morning Market Movers: 707 Cayman, Zhongchao, NVE Corporation, Medpace See Big Swings | 829 | AFX News | BEIJING (dpa-AFX) - At 8:25 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| Mi | Zhongchao Inc. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 03.07. | Zhongchao Stock Surges 200% After Hours: Here's Why | 16 | Benzinga.com | ||
| 25.06. | Zhongchao announces 1-for-3 share consolidation | 1 | Seeking Alpha | ||
| ZHONGCHAO Aktie jetzt für 0€ handeln | |||||
| 25.06. | Zhongchao kündigt Aktienzusammenlegung im Verhältnis 1:3 an | 7 | Investing.com Deutsch | ||
| 25.06. | Zhongchao announces 1-for-3 reverse stock split effective Sunday | 2 | Investing.com | ||
| 25.06. | Zhongchao Inc. Announces 1-for-3 Share Consolidation | 358 | PR Newswire | SHANGHAI, June 25, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen | |
| 23.06. | Zhongchao Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 05.06. | Zhongchao Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.06. | Zhongchao führt am Sonntag Reverse-Aktiensplit im Verhältnis 1:31 durch | 1 | Investing.com Deutsch | ||
| 04.06. | Zhongchao Inc. Announces 1-for-31 Share Consolidation | 226 | PR Newswire | SHANGHAI, June 4, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen | |
| 29.05. | Zhongchao prices $5 million public offering at $0.54 per unit | 18 | Investing.com | ||
| 29.05. | Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering | 210 | PR Newswire | SHANGHAI, May 29, 2026 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ: ZCMD), a platform-based internet technology company offering services... ► Artikel lesen | |
| 22.05. | Zhongchao Inc. - F-1/A, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 07.05. | Zhongchao Inc. - F-1, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 03.04. | Zhongchao Inc. - 20-F, Annual and transition report of foreign private issuers | - | SEC Filings | ||
| 18.03. | Zhongchao Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 26.02. | Zhongchao announces 1-for-8 share consolidation | 2 | Seeking Alpha | ||
| 26.02. | Zhongchao Inc. Announces 1-for-8 Share Consolidation | 207 | PR Newswire | SHANGHAI, Feb. 26, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services... ► Artikel lesen | |
| 10.02. | Zhongchao Inc. - 6-K, Report of foreign issuer | 1 | SEC Filings |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 13,300 | -1,41 % | EQS-News: Eckert & Ziegler SE: BaFin-Prüfung betrifft Bilanzierung der Pentixapharm-Abspaltung im Konzernabschluss 2024 - möglicher Gewinn aus aufgegebenem Geschäftsbereich ohne Auswirkung auf operative Kennzahlen | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Sonstiges
BaFin-Prüfung betrifft Bilanzierung der Pentixapharm-Abspaltung im Konzernabschluss 2024 - möglicher Gewinn aus aufgegebenem... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,070 | -4,36 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| SYNLAB | - | - | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | -9,84 % | NuGen Medical Devices Inc.: NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance | Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn Wound Irrigation Solution | BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced it has received a new 510(k)... ► Artikel lesen | |
| UNIDOC HEALTH | 0,050 | -6,72 % | UniDoc Health Corp.: UniDoc Connect Surpasses One Million Patient Visits | Company Records 250,000 Patient Visits in First Six Months Since AMD Purchase, Then Triples to 750,000 in the Following Six Months VANCOUVER, BC / ACCESS Newswire / June 9, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| CO-DIAGNOSTICS | 2,070 | -1,43 % | Co-Diagnostics joint venture begins TB test clinical studies in India | ||
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| QUIDELORTHO | 14,490 | 0,00 % | QuidelOrtho Corporation: QuidelOrtho Appoints Micah Young as Chief Financial Officer | Seasoned medical technology finance executive brings more than two decades of leadership at global public companies SAN DIEGO, June 23, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq:... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 202,80 | +1,15 % | ROUNDUP: Quest Diagnostics Boosts FY26 Outlook; Shares Up 5.7% | WASHINGTON (dpa-AFX) - While reporting financial results for the second quarter on Thursday, diagnostic services firm Quest Diagnostics, Inc. (DGX) raised its earnings, adjusted earnings and... ► Artikel lesen | |
| VERU | 2,250 | 0,00 % | Top Biotech Gainers: VERU Teams Up With NVO, ABSI On Watch, ALVO Resubmits BLAs To FDA... | REYKJAVIK (dpa-AFX) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business... ► Artikel lesen | |
| LIFEWARD | 7,050 | +0,71 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| SENSEONICS | 4,080 | +0,99 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,950 | +2,60 % | Tempest Therapeutics: Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T | Tempest's TPST-4003 is a next-generation in vivo CAR-T candidate combining proprietary CD7-targeted mRNA/LNP delivery with a dual-target CD19/BCMA CAR construct designed to enable broad B-cell lineage... ► Artikel lesen |
ZHONGCHAO INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,400 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZHONGCHAO INC finden Sie auf Wallstreet Online.